Basel, Switzerland

Virginie Le Brun

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Catalym Gmbh, Julius-Maximilians-Universitat Wurzburg. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Virginie Le Brun. Retrieved from https://idiyas.com/inventor/virginie-le-brun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Virginie Le Brun: Innovator in Cancer Treatment

Introduction

Virginie Le Brun is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative research and development.

Latest Patents

Virginie holds a patent for an "Anti-GDF15 Antibody and a Dosage Regimen for the Treatment of Cancer." This patent represents her commitment to advancing therapeutic options for cancer patients.

Career Highlights

Throughout her career, Virginie has worked with prestigious institutions, including Julius-Maximilians-Universität Würzburg and Catalym GmbH. Her work in these organizations has been instrumental in her research and development efforts.

Collaborations

Virginie has collaborated with esteemed colleagues, including Eugen Leo and Markus Haake. These partnerships have enhanced her research and contributed to her success in the field.

Conclusion

Virginie Le Brun's innovative work in cancer treatment exemplifies her dedication to improving patient outcomes. Her contributions through her patent and collaborations highlight her impact in the medical research community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…